Nephros NEPH
NASDAQ NEPH
$4.47 -0.07 (-1.59%)
At close: Sep 11, 2026 · 4:00 PM EDT

Nephros (NEPH) Consolidated Net Income (2010 - 2026)

Nephros (NEPH) posted Consolidated Net Income of $1.2 million for Q2 2026, up 1097.0% on a QoQ basis from $100000.0 in Q1 2026, and up 405.06% year-over-year from $237000.0 in Q2 2025.

Analysis

Nephros (NEPH) Consolidated Net Income (2010 - 2026) Analysis & Trends

Nephros has reported Consolidated Net Income for 17 years, with the latest figure at $1.2 million in Q2 2026.

  • On a quarterly basis, Consolidated Net Income rose 405.06% year-over-year to $1.2 million in Q2 2026; TTM through Jun 2026 was $1.5 million, a 14.88% increase from a year earlier, with the FY2025 full-year figure at $1.0 million, up 2447.5% from the prior year.
  • Consolidated Net Income was $1.2 million for Q2 2026 at Nephros, up from $100000.0 in the prior quarter.
  • The five-year high for Consolidated Net Income was $1.2 million in Q2 2026, with the low at -$3.2 million in Q3 2022.
  • Average Consolidated Net Income over 5 years is -$364833.3, with a median of -$200000.0 recorded in 2023.
  • The sharpest annual moves came in 2022 and 2026: Consolidated Net Income tumbled 172.22% in 2022, then surged 405.06% in 2026.
  • Over 5 years, Consolidated Net Income stood at -$818000.0 in 2022, then dropped by 1.96% to -$834000.0 in 2023, then surged by 143.65% to $364000.0 in 2024, then slumped by 131.04% to -$113000.0 in 2025, then soared by 1159.29% to $1.2 million in 2026.
  • The last three Consolidated Net Income figures came in at $1.2 million (Q2 2026), $100000.0 (Q1 2026), and -$113000.0 (Q4 2025), per Business Quant data.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Consol Net Inc. (Qtr)
1 Abbott Laboratories 178.01 Bn 172.41 Bn 7.27 Bn 928.00 Mn
2 Intuitive Surgical 131.29 Bn 126.08 Bn 1.96 Bn 823.20 Mn
3 Medtronic 116.38 Bn 107.56 Bn 6.34 Bn 1.48 Bn
4 Stryker 106.01 Bn 102.53 Bn 4.50 Bn 1.28 Bn
5 Boston Scientific 63.40 Bn 62.86 Bn 3.85 Bn 905.00 Mn
6 Edwards Lifesciences 48.89 Bn 44.64 Bn 1.35 Bn 241.40 Mn
7 Alcon 32.59 Bn 31.13 Bn 1.68 Bn -92.00 Mn
8 Dexcom 31.84 Bn 29.89 Bn 830.00 Mn 249.10 Mn
9 Steris 20.61 Bn 20.13 Bn 684.20 Mn 201.00 Mn
10 Nephros 48.31 Mn 43.62 Mn 4.03 Mn 1.20 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 1.20 Mn
Mar 31, 2026 100,000.00
Dec 31, 2025 -113,000.00
Sep 30, 2025 337,000.00
Jun 30, 2025 237,000.00
Mar 31, 2025 540,000.00
Dec 31, 2024 364,000.00
Sep 30, 2024 183,000.00
Jun 30, 2024 -289,000.00
Mar 31, 2024 -208,000.00
Dec 31, 2023 -834,000.00
Sep 30, 2023 -192,000.00
Jun 30, 2023 -422,000.00
Mar 31, 2023 -295,000.00
Dec 31, 2022 -818,000.00
Sep 30, 2022 -3.19 Mn
Jun 30, 2022 -1.21 Mn
Mar 31, 2022 -1.96 Mn
Dec 31, 2021 -1.04 Mn
Sep 30, 2021 -1.17 Mn